about
Laboratory testing for prescription opioidsApplication of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluidsInfluence of sampling on the determination of warfarin and warfarin alcohols in oral fluidMeasuring substance use in the club setting: a feasibility study using biochemical markers.Salivary Diagnostics in Pediatrics: Applicability, Translatability, and LimitationsRapid Identification of Psychoactive Drugs in Drained Gastric Lavage Fluid and Whole Blood Specimens of Drug Overdose Patients Using Ambient Mass Spectrometry.Saliva as a diagnostic fluid.Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urineExcretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration.Detection of strep throat causing bacterium directly from medical swabs by touch spray-mass spectrometry.Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagentCannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.The clinical and forensic toxicology of Z-drugs.Methadone disposition in oral fluid during pharmacotherapy for opioid-dependenceImpact of oral fluid collection device on cannabinoid stability following smoked cannabisSalivary markers for oral cancer detectionPharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administrationHigh-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry.Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.Oral fluid nicotine markers to assess smoking status and recency of useA Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry.Current knowledge on cannabinoids in oral fluid.Cannabis effects on driving lateral control with and without alcoholQuantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.Concentrations of Morphine and Codeine in Paired Oral Fluid and Urine Specimens Following Ingestion of a Poppy Seed Roll and Raw Poppy SeedsOral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluidMining the salivary proteome with grating-coupled surface plasmon resonance imaging and surface plasmon coupled emission microarrays.Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?Conducting Rapid Street Assessment of Drug Users in New York City Using Oral Fluid and Brief Interviews: A Feasibility Study.Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.Objective Testing: Urine and Other Drug TestsOral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
P2860
Q27015926-B83B4624-896E-4D37-876E-AA2D21549BA1Q27312152-4E98FF4E-7C5A-408E-954D-9872D354B250Q28542544-D84FB760-230D-48B9-84C6-8736844073BEQ30412845-DD370A35-6C0B-468A-BFDD-824942CC7F5AQ33580937-781AA483-AB6B-4950-975B-A06D5CBA7906Q33738114-4357DC5D-3CA8-4585-B4C4-54A4BD2221C3Q33752749-E3B06DAA-180C-4990-B989-B38F2E58F97BQ34022671-794C2071-1931-4305-9E35-49284DF7ED2EQ34025985-5B6AF009-E906-4E89-A5E3-B5E8F8610F33Q34098186-F7A4E9A6-7FC6-4730-81CC-E1BC66B2F61AQ34115227-900869FE-1D50-49A2-8508-2F89F6086064Q34216957-E4CCF991-1398-4914-BFDB-E9FA7B2B39B5Q34327511-FF8DFCDF-04C7-4B4D-9DB8-3AFE2CBDE75BQ34448467-15D17843-2517-45D3-A7FF-08825FE9E110Q34809118-9286A47B-F30A-453B-8FB0-89DD9C9A08A8Q35036328-F93F8EF0-BD6A-45AF-ADE4-40269EFF0568Q35157933-A1A4D7E0-6644-49B7-AE33-9C8FD9BD1564Q35184660-BFF239AB-9016-4331-BAFF-B87ED606AB94Q35209227-D51A86D9-3775-43E2-A4F3-21FF0D140A12Q35228063-CF857498-8069-4D5D-B2F8-2F28185CEDF2Q35228351-88FDD890-527D-4A2B-83F6-72040BBB7271Q35762993-CD3BE8F6-1634-438F-9A9B-B99E4A76B3CCQ35870084-7E146E5A-2FE4-4F68-A0B9-4B6CF42D08ABQ35885493-14C72C65-35B6-48FE-9506-ECF0EDA195DDQ35940339-6FB8C431-A10F-41E3-B6D1-719E841168D1Q35952146-C0B29E05-7951-493E-93DA-C6B204CECFD9Q35963506-5C48F217-3C03-4AD5-9EC3-29620265184BQ36062684-7C537DE3-5FD8-41F8-A7A3-AE6B956F48A0Q36073197-00CAAB33-7C8A-4D1F-89D7-1D831D4BA490Q36275417-5CE3C1F2-3D9A-4C8C-AEC0-D3B2C7036490Q36288409-2FE1279F-EC73-45ED-A051-BEF9CA079614Q36568260-2933AA08-9F2C-49DE-8274-5D4D766B6670Q36600912-00231E0A-783E-43C0-8643-7EBBC653AC30Q36729404-20312B53-8C43-4F6C-961E-C4B9A0A62334Q36775882-AA250A59-59B0-4380-9DB0-EE82B5E4B30CQ37029564-D81A23DC-503A-4568-9DD8-FBB29B4DA467Q37037872-96A64B54-BF4C-452A-A5CB-EECAF025948EQ37136230-ED6B6B97-6868-4695-9E0E-478911C74C84Q37172153-0B2D7967-0B65-4842-A9CF-4323E2485EDCQ37297012-0ACDFF2F-196A-43E7-9D64-4519577C8AFB
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Oral fluid testing for drugs of abuse.
@ast
Oral fluid testing for drugs of abuse.
@en
type
label
Oral fluid testing for drugs of abuse.
@ast
Oral fluid testing for drugs of abuse.
@en
prefLabel
Oral fluid testing for drugs of abuse.
@ast
Oral fluid testing for drugs of abuse.
@en
P2860
P1433
P1476
Oral fluid testing for drugs of abuse.
@en
P2093
Wendy M Bosker
P2860
P304
P356
10.1373/CLINCHEM.2008.108670
P407
P577
2009-09-10T00:00:00Z